# Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

> **NCT00089453** · PHASE1 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Cyclophosphamide
- **DRUG:** Melphalan
- **DRUG:** Fludarabine
- **DRUG:** Bortezomide
- **PROCEDURE:** Leukapheresis
- **DRUG:** Interleukin
- **PROCEDURE:** Infusion #1
- **PROCEDURE:** Leukapheresis #2
- **PROCEDURE:** Infusion #2
- **PROCEDURE:** Auto Graft

## Key facts

- **NCT ID:** NCT00089453
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089453, "Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00089453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*